GILD- Gilead Sciences, Inc.

Name: Gilead Sciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Gilead Sciences, Inc. (GILD) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. GILD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	O'Day Daniel Patrick	626.3K	$79.13M	-15,000
Other	Berger Dietmar	46.9K	$5.93M	-
Other	Wilfong Diane E.	46.6K	$5.89M	-
VP	Telman Deborah H	44.2K	$5.58M	-
Other	Mercier Johanna	27.9K	$3.52M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 3, 2021	Whitley Richard James	Director	Sale+OE	20,282	$64.57	$1,309,655.39	-39.5%	+5.0%	-4.3%
Mar 11, 2021	Pletcher Brett A	EVP,Corp Affairs &Gen Counsel	Sale+OE	1,486	$63.36	$94,152.96	-4.8%	+10.1%	-4.1%
Feb 10, 2021	Pletcher Brett A	EVP,Corp Affairs &Gen Counsel	Sell	1,975	$67.41	$133,134.75	-6.4%	+1.0%	-4.3%
Feb 1, 2021	Pletcher Brett A	EVP,Corp Affairs &Gen Counsel	Sell	9,711	$65.97	$640,632.73	-25.2%	-	-
Jan 31, 2021	Gilead Sciences Inc71	10% Owner	Buy	5,650,000	$39.00	$220,350,000.00	+68.4%	-	-
Aug 17, 2020	Parsey Merdad52	Chief Medical Officer	Sell	182	$68.32	$12,434.24	-100%	-	-
Jun 23, 2020	Rodriguez Javier55	Director	Sell	189	$75.50	$14,269.50	-100%	-	-
May 5, 2020	Pletcher Brett A	EVP,Corp Affairs &Gen Counsel	Sale+OE	13,210	$79.23	$1,046,640.19	-47.4%	-	-
May 4, 2020	Wilfong Diane E.48	SVP, Controller &CAO	Sale+OE	12,264	$80.09	$982,220.08	-51.8%	-	-
May 4, 2020	Cogan John Francis	Director	Sale+OE	2,416	$81.75	$197,508.00	-4.2%	-	-

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC